Oral Propanolol for Surgically Inaccessible Cavernous Malformations

Phase 1 Unknown 346 enrolled University of Virginia

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the role of propranolol as an alternative treatment for cavernous malformation in patients that may not be ideal candidates for surgery.

Timeline

Start: 2018-02-07
Primary completion: 2019-01
Completion: 2019-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Propranolol	Small molecule	—	Oral

Oral Propanolol for Surgically Inaccessible Cavernous Malformations

Summary

Timeline

Drugs

Indications